TREATMENT OF ANTERIOR-CHAMBER FIBRIN FOLLOWING CATARACT-SURGERY WITH TISSUE PLASMINOGEN-ACTIVATOR

被引：24

作者：

LESSER, GR

OSHER, RH

WHIPPLE, D

ABRAMS, GW

CIONNI, RJ

机构：

[1] Department of Ophthalmology, Henry Ford Hospital, Detroit, Michigan

[2] Cincinnati Eye Institute, Cincinnati, Ohio

[3] Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin

来源：

JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 1993年 / 19卷 / 02期

关键词：

ANTERIOR CHAMBER FIBRINOUS EXUDATES; TISSUE PLASMINOGEN ACTIVATOR;

D O I：

10.1016/S0886-3350(13)80961-3

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Three patients who developed anterior chamber fibrinous exudates after cataract surgery were treated with tissue plasminogen activator injected into the anterior chamber. There was prompt dissolution of the fibrinous exudates and no observed complications. When fibrinous exudates occur in high-risk patients after cataract surgery, tissue plasminogen activator provides an excellent means of clearing the fibrin.

引用

页码：301 / 305

页数：5

共 35 条

[1]

Rijken DC, Collen D, Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture, J Biol Chem, 256, pp. 7035-7041, (1981)

[2]

Pennica D, Holmes WE, Kohr WJ, Et al., Cloning and expression of human tissue type plasminogen activator with cDNA in E coli, Nature, 301, pp. 214-221, (1983)

[3]

Hoylaerts M, Rijken DC, Lijnen HR, Collen D, Kinetics of the activation of plasminogen by human tissue plasminogen activator, J Biol Chem, 257, pp. 2912-2919, (1982)

[4]

Dano K, Andreasen PA, Grondahl-Hansen J, Et al., Plasminogen activators, tissue degradation, and cancer, Adv Cancer Res, 44, pp. 139-266, (1985)

[5]

Snyder RW, Lambrou FH, Williams GA, Intraocular fibrinolysis with recombinant human tissue plasminogen activator

[6]

experimental treatment in a rabbit model, Arch Ophthalmol, 105, pp. 1277-1280, (1987)

[7]

Lambrou FH, Snyder RW, Williams GA, Lewandowski M, Treatment of experimental intravitreal fibrin with tissue plasminogen activator, Am J Ophthalmol, 104, pp. 619-623, (1987)

[8]

Johnson RN, Olsen K, Hernandez E, Tissue plasminogen activator treatment of postoperative intraocular fibrin, Ophthalmology, 95, pp. 592-596, (1988)

[9]

Williams GA, Lambrou FH, Jaffe GA, Et al., Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator, Arch Ophthalmol, 106, pp. 1055-1058, (1988)

[10]

Jaffe GJ, Lewis H, Han DP, Et al., Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator, Am J Ophthalmol, 108, pp. 170-175, (1989)

← 1 2 3 4 →